Dissolution test for lamivudine tablets: Optimization and statistical analysis

Journal of Pharmaceutical and Biomedical Analysis

Volumn 42, Issue 5, 2006, Pages 601-606

  Fernandes, Christian ^a   Junqueira, Roberto Gonçalves ^a   Campos, Ligia Maria Moreira ^a   Pianetti, Gerson Antônio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Anti HIV drugs; Dissolution test; Duncan test; Generic drug; Lamivudine

Indexed keywords

ETHYL CELLULOSE; EUDRAGIT; HYDROCHLORIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; LAMIVUDINE; MACROGOL; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; POLYSORBATE 80; POVIDONE; SILICON DIOXIDE; STARCH; STARCH GLYCOLATE SODIUM; TALC; TITANIUM DIOXIDE; WATER;

ANALYSIS OF VARIANCE; APPARATUS; ARTICLE; CULTURE MEDIUM; DRUG DETERMINATION; DRUG SCREENING; DRUG SOLUBILITY; FACTORIAL DESIGN; INTERMETHOD COMPARISON; PH; POST HOC ANALYSIS; PRIORITY JOURNAL; REACTION TIME; SAMPLE; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TABLET;

ANALYSIS OF VARIANCE; ANTI-HIV AGENTS; HYDROCHLORIC ACID; HYDROGEN-ION CONCENTRATION; LAMIVUDINE; QUALITY CONTROL; SOLUBILITY; TABLETS; WATER;

EID: 33750419104     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.05.009     Document Type: Article

References (19)

1. Clercq E. Biochim. Biophys. Acta 1587 (2002) 258-275
2. Anderson K.S. Biochim. Biophys. Acta 1587 (2002) 296-299
3. Fernandes C., Moreira-Campos L.M., and Pianetti G.A. Braz. J. Pharm. Sci. 39 (2003) 381-389
4. Jozwiakowski M.J., Nguyen N.T., Sisco J.M., and Spancake C.W. J. Pharm. Sci. 85 (1996) 193-199
5. WHO. Proposal to Waive In Vivo Bioequivalence Requirements for the WHO Model List of Essential Medicines Immediate Release Solid Oral Dosage Forms (2005), World Health Organization, Geneva
6. Brazil, Health Ministry, Policy of AIDS drugs of Health Ministry/Brazil: , 10 October, 2005.
7. Brazil, Health Ministry, Documents, recommendations, and technical reports: , 15 September, 2005.
8. Storpirtis S., Oliveira P.G., Rodrigues D., and Marinho D. Braz. J. Pharm. Sci. 35 (1999) 1-16
9. Banker G., and Anderson N.R. Tablets. In: Lachman L., Lieberman H.A., and Kanig J.L. (Eds). The Theory and Practice of Industrial Pharmacy. third ed. (1986), Lea & Febiger, Philadelphia
10. FDA. Guidance for Industry: Dissolution Testing of Immediate Release Oral Dosage Forms (1997), Food and Drug Administration, Rockville
11. FDA. Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics System (2000), Food and Drug Administration, Rockville
12. Furlanetto S., Maestrelli F., Orlandini S., Pinzauti S., and Mura P. J. Pharm. Biomed. Anal. 32 (2003) 159-165
13. Frost S.M.A. Dissol. Tech. (Feb. 2004) 19-21
14. Brazil, National Agency of Sanitary Vigilance, List of reference drugs, Brasília, 2005.
15. The United States Pharmacopoeia, 26th ed., United States Pharmacopeial Convention, Rockville, 2003.
16. ICH Q2(R1), International Conference on Harmonisation, Validation of Analytical Procedures: Text and Methodology, 2005.
17. Snedecor G.W., and Cochran W.G. Statistical Methods (1989), Iowa State University, Ames
18. Farmacopéia brasileira, 4th ed., Atheneu, São Paulo, Parte II, Fascículo 4, p. 200.1., 1988-2003
19. Fernandes C. Estudo de equivalência farmacêutica de comprimidos de lamivudina 150 mg Belo Horizonte Dissertação de mestrado Faculdade de Farmácia (2001), Universidade Federal de Minas Gerais, Brasil